Diagnostic accuracy of 10/66 dementia protocol in Māori kaumātua (elders) living in Aotearoa New Zealand.


Journal

The New Zealand medical journal
ISSN: 1175-8716
Titre abrégé: N Z Med J
Pays: New Zealand
ID NLM: 0401067

Informations de publication

Date de publication:
21 01 2022
Historique:
entrez: 21 6 2022
pubmed: 22 6 2022
medline: 24 6 2022
Statut: epublish

Résumé

Dementia is an important health concern for Māori and therefore it is essential to explore the extent and impact of dementia in this community. The 10/66 dementia protocol, a widely used research tool for measuring the prevalence of dementia, was developed to minimise cultural and educational bias in comparisons of dementia prevalence across different countries and/or cultures. The aims of this study are to (i) adapt the 10/66 dementia protocol for use in research within the Māori community and (ii) test the diagnostic accuracy of the adapted (ie, Māori-friendly) 10/66 dementia protocol against the reference standard of a clinical diagnosis of dementia (or no dementia). The sample included Māori aged 65 and over who had been assessed at a local memory service. Ten dementia cases and 10 controls were included. The sample was further enriched by the inclusion of 6 controls from a concurrent dementia-prevalence feasibility study in the local community. The Māori-friendly 10/66 dementia protocol was measured against the reference standard. Sensitivity, specificity, positive and negative predictive values and Youden's Index were calculated. The Māori-friendly 10/66 dementia protocol had a sensitivity of 90.0% (95% CI 62.8-99.4), specificity of 93.8% (95% CI 75.3-99.6), positive predictive value of 90.0% (95% CI 62.8-99.4), negative predictive value of 93.8% (95% CI 75.3-99.6) and Youden's Index of 0.83. Our study results provide preliminary evidence that the Māori-friendly 10/66 dementia protocol has adequate discriminatory abilities for the diagnosis of dementia. Our study also demonstrates that the Māori-friendly 10/66 dementia protocol has the potential to be used in a dementia-population-based study for Māori in Aotearoa New Zealand.

Identifiants

pubmed: 35728129

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

42-53

Déclaration de conflit d'intérêts

Nil.

Auteurs

Adrian Martinez-Ruiz (A)

PhD student, Department of Psychological Medicine, The University of Auckland, Auckland, New Zealand.

Sarah Cullum (S)

Associate Professor, Department of Psychological Medicine, The University of Auckland, Auckland, New Zealand.

Gary Cheung (G)

Senior Lecturer, Department of Psychological Medicine, The University of Auckland, Auckland, New Zealand.

Susan Yates (S)

Clinical Psychologist/Neuropsychologist/Research Fellow, Department of Psychological Medicine, The University of Auckland, Auckland, New Zealand.

Rita Krishnamurthi (R)

Associate Professor, The National Institute for Stroke and Applied Neurosciences, Auckland University of Technology, Auckland.

Claudia Rivera Rodriguez (CR)

Lecturer, Department of Statistics, The University of Auckland, Auckland, New Zealand.

Ngaire Kerse (N)

Joyce Cook Chair in Ageing Well, School of Population Health, The University of Auckland, Auckland, New Zealand.

Makarena Dudley (M)

Te Rarawa, Te Aupōuri, Ngāti Kahu, Senior Lecturer, School of Psychology, The University of Auckland, Auckland, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH